Report Categories
View AllRecent Articles
View All
Gilead Sciences Inc GILD Schedules Participation at Four Leading Q2 2026 Healthcare Investor Conferences to Update Stakeholders on Pipeline and Operational Milestones
ARQ Arq shares surge 12 after beating earnings estimates by 50 revenue climbs 10 yearoveryear
TOL Toll Brothers notches modest Q1 2026 EPS beat shares drop 162 as investors take a cautious stance
What synergies PennyMac PMTB captured this quarter